I want to evaluate therapeutic efficacy, or at least in vivo behaviour, of various radiopharmaceuticals targeting bone lesions in cancer therapy. I will be looking more towards fundamental behaviour of these radiopharmaceuticals.

More Janke Kleynhans's questions See All
Similar questions and discussions